Humana (HUM) · Health Insurance
Humana Q2 2026 earnings: summary, key numbers & outlook
Results filed 29 Jul 2026 · Quarter ended 30 Jun 2026
Press release ↗Investor relations ↗
Summaries and transcripts are machine-generated and can contain errors.
In brief
Humana's individual Medicare Advantage membership is on track to grow about 25% this year, while CenterWell primary care added 27% more patients and Humana won a statewide Illinois Medicaid contract.
Humana's customer-led benefit strategy and revised customer service approach are driving individual Medicare Advantage growth, with year-to-date membership up about 1,204,000, or 23%. Stand-alone Part D grew about 50%, mostly in Basic and Value plans. CenterWell primary care reached about 622,000 patients and 398 centers, helped by The Villages Health and MaxHealth acquisitions. Humana also won Illinois Medicaid and had its Florida contract extended to 2035.
Management is steering toward a return to a pre-tax margin of at least 3% in 2028. It plans to get there through 2027 individual MA bids, a push back to top-quartile Star Ratings, and cost discipline. The main tension is that a large base of new members runs at a higher benefit ratio, and the 2026 Star Ratings shortfall still weighs on the year. Management has also said it expects to give an investor update on December 10, 2026.
No call transcript for this quarter, so this summary also draws on: The Motley Fool (via Webull) ↗.
Key numbers
- Total revenues · GAAP
- $40.9B
- Diluted EPS · GAAP
- $5.73
- Adjusted diluted EPS · non-GAAP
- $7.61
- Insurance segment benefit ratio · GAAP
- 91.2%
vs $32,388 in 2Q25
vs $4.51 in 2Q25
vs $6.27 in 2Q25
vs 89.9% in 2Q25
| Segment or metric | Value | Change |
|---|---|---|
| Insurance segment revenues | $39.1B | vs $31,094 in 2Q25 |
| CenterWell segment revenues | $6.8B | vs $5,537 in 2Q25 |
| Individual MA membership growth (YTD) | approximately 1,204,000 | up 23% year to date |
| Individual stand-alone PDP growth (YTD) | approximately 1,139,000 | up 50% year to date |
| Group MA membership growth (YTD) | approximately 159,000 | up 28% year to date |
| Medicaid membership growth (YTD) | approximately 93,000 | |
| CenterWell primary care patients | approximately 622,000 | up 130,900, or 27%, since December 31, 2025 |
| CenterWell primary care centers | 398 | up 63 centers, or 19%, year over year |
Where each number comes from
- Total revenues: “Humana Inc. Summary of Results($ in millions, except per share amounts) | 2Q26 (a) | 2Q25 (a) | YTD 2026 (a) | YTD 2025 (a) Revenues | $40,867 | $32,388 | $80,515 | $64,500”
- Diluted EPS: “Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis”
- Adjusted diluted EPS: “Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis”
- Insurance segment benefit ratio: “2Q26 Insurance segment GAAP benefit ratio of 91.2 percent, in line with management's guidance of 'slightly above 91 percent'; affirms full year (FY) 2026 Insurance segment benefit ratio guidance”
- Insurance segment revenues: “Insurance Segment Results($ in millions) | 2Q26 (a) | 2Q25 (a) | YTD 2026 (a) | YTD 2025 (a) Revenues | $39,140 | $31,094 | $77,199 | $62,031”
- CenterWell segment revenues: “CenterWell Segment Results($ in millions) | 2Q26 | 2Q25 | YTD 2026 | YTD 2025 Revenues | $6,790 | $5,537 | $12,890 | $10,632”
- Individual MA membership growth (YTD): “2Q26 YTD membership increase of approximately 1,204,000, or 23%, is tracking in line with our FY 2026 expectation of approximately 25% membership growth”
- Individual stand-alone PDP growth (YTD): “2Q26 YTD membership growth of approximately 1,139,000, or 50%, which is largely concentrated in our Basic and Value PDP plans”
- Group MA membership growth (YTD): “2Q26 YTD membership growth of approximately 159,000, or 28%, is in line with expectations of growth of approximately 150,000 members in FY 2026”
- Medicaid membership growth (YTD): “2Q26 YTD Medicaid member growth of approximately 93,000, largely driven by the start of programs in Michigan, Illinois and South Carolina”
- CenterWell primary care patients: “Serving approximately 622,000 patients as of June 30, 2026, an increase of 130,900 patients, or 27%, from December 31, 2025.”
- CenterWell primary care centers: “Operating 398 centers as of June 30, 2026, representing growth of 63 centers, or 19%, year over year”
Copied from the press release ↗ and other documents in the SEC filing ↗. A figure is published only if its sentence is in those documents.
| From the filing | Q2 2026 | vs year ago | vs last quarter |
|---|---|---|---|
| Revenue | $40.9B | +26.2% | +3.1% |
| Operating income | $1.4B | +23.9% | −22.5% |
| Net income | $694.0M | +27.3% | −41.5% |
| Diluted EPS | $5.73 | +27.1% | −41.7% |
| Free cash flow | $1.8B | +58.5% | +61.9% |
| Operating margin | 3.3% | −0.1 pts | −1.1 pts |
Calculated by code from XBRL, not by the model.
Outlook
| Metric | Period | Outlook |
|---|---|---|
| Adjusted EPS | FY 2026 Adjusted EPS | at least $9.00 |
| GAAP EPS | FY 2026 GAAP EPS | at least $6.52 |
| Consolidated revenues | FY 2026 | At least $160 billion |
| Insurance segment benefit ratio | FY 2026 | 92.75% +/- 25 bps |
| Consolidated operating cost ratio | FY 2026 | 10.0% +/- 25 bps |
| Effective tax rate | FY 2026 | approximately 25.5% |
| Cash flows from operations | FY 2026 | $2.5 billion to $2.9 billion |
| Capital expenditures | FY 2026 | approximately $650 million |
| Adjusted EPS | third quarter of 2026 | approximately ($1.00) |
| Insurance segment benefit ratio | third quarter of 2026 | slightly above 94% |
Key takeaways
Individual Medicare Advantage growth is on plan
Year-to-date individual MA membership rose about 1,204,000, or 23%, against a full-year expectation of about 25%. Management credits new sales and better retention from its customer-led benefit strategy and changes to customer service.
CenterWell primary care is scaling through acquisitions
Primary care served about 622,000 patients, up 27% since year-end, across 398 centers. Growth came from de novo centers, mature centers and IPAs, with The Villages Health and MaxHealth adding centers.
Humana expanded its Medicaid footprint
Humana won a statewide Illinois HealthChoice Medicaid contract, going live in January 2027, as the only new entrant alongside five incumbents. Its Florida contract was extended through January 31, 2035, though procurement challenges continue on Texas and Georgia awards.
Stand-alone Part D membership has surged
Individual PDP membership grew about 1,139,000, or 50%, year to date, concentrated in Basic and Value plans. That is in line with Humana's expectation of about 1 million members for the year.
Star Ratings recovery is central to the 2028 plan
Management is focused on top-quartile Stars results in Bonus Year 2028 and reports that the rate of improvement outpaced the four-year historical growth rate in 11 of 12 selected HEDIS and Patient Safety measures. Humana's appeal of the 2025 Star Ratings ruling remains pending.
Charts
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $29.2B * |
| Q1 2025 | $32.1B |
| Q2 2025 | $32.4B |
| Q3 2025 | $32.6B |
| Q4 2025 | $32.5B * |
| Q1 2026 | $39.6B |
| Q2 2026 | $40.9B |
| Q3 2026 | $41.2B |
Data
| Q1 2025 | $10.30 |
| Q2 2025 | $4.51 |
| Q3 2025 | $1.62 |
| Q1 2026 | $9.83 |
| Q2 2026 | $5.73 |
| Q3 2026 | $1.33 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q4 2024 | -1.9% |
| Q1 2025 | 6.3% |
| Q2 2025 | 3.4% |
| Q3 2025 | 1.2% |
| Q4 2025 | -2.5% |
| Q1 2026 | 4.4% |
| Q2 2026 | 3.3% |
| Q3 2026 | 0.2% |
Data
| Q4 2024 | -$682.0M |
| Q1 2025 | $236.0M |
| Q2 2025 | $1.2B |
| Q3 2025 | $836.0M |
| Q4 2025 | -$1.9B |
| Q1 2026 | $1.1B |
| Q2 2026 | $1.8B |
| Q3 2026 | $2.0B |
Operating cash flow minus capital expenditure, from cash flow statements.
Questions
How fast is Humana's Medicare Advantage business growing?
Individual MA membership is up about 1,204,000, or 23%, year to date, tracking Humana's full-year expectation of about 25% growth. Group MA is up about 159,000 and stand-alone PDP about 1,139,000.
What is happening at CenterWell?
CenterWell primary care reached about 622,000 patients and 398 centers, growing 27% in patients since year-end, partly through The Villages Health and MaxHealth acquisitions. Pharmacy volumes are rising with Humana membership and a growing client base outside Humana.
What Medicaid progress did Humana report?
Humana won a statewide Illinois HealthChoice contract starting January 2027 and had its Florida contract extended through January 31, 2035. It is still working through procurement challenges on awards in Texas and Georgia.
What is Humana's long-term strategy?
Management is targeting a sustainable pre-tax margin of at least 3% in 2028, relying on 2027 individual MA bids, a return to top-quartile Star Ratings, and discipline in pricing, clinical care and costs. It plans a virtual investor update on December 10, 2026.
Are medical costs behaving as Humana expected?
Management says medical and pharmacy cost trends are in line with its 'high single digit' expectation for both new and existing members. It has seen slight favorability in inpatient care, mostly among members with value-based providers.
Documents
SEC filing